The alarming rise and spread of antimicrobial resistance is an increasing global challenge and there is considerable interest and an acknowledged benefit in the [...]
Proceeds will be used to establish clinical proof of concept for three novel haematological cancer programs UCL Business spinout company, Autolus Limited, a cli [...]
• The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development • Speaking from the W [...]
AUTO3 is the first dual targeting CAR-T cell therapy to enter clinical studies targeting CD19 and CD22 with independently-acting CARs. UCL Business spinout comp [...]
AUTO2 is the first dual targeting CAR-T Cell therapy in clinical development for the treatment of multiple myeloma UCL Business spinout company, Autolus Limited [...]
UCL academics will assist TCB with development of treatment for leukemia. Clinical programme will see first patients treated in 2018 Scottish immunotherapy comp [...]
Most cameras just record colour but now the 3D shapes of objects, captured through only a single lens, can be accurately estimated using new software developed [...]
The first patient in an international trial of a new liver dialysis system has been recruited at the Royal Free Hospital in London. The device, called DIALIVE, [...]
Chirp, a UCLB spinout company, has partnered with Chicago-based toy company Hijinx to create toys based on Netflix original series Beat Bugs. The worldwide excl [...]
UCLB hosted its annual summer reception where guests enjoyed refreshing drinks and delicious canapés under UCL’s prestigious portico. UCLB’s Managing Director, [...]
